← Tra cứu cổ phiếu
Viewing Quý 1/2026Latest period →

iShareInvest Research

HNX · Quý 1/2026

MKV

Dược thú Y Cai Lậy

Analysis of business results & financial statements · Quý 1/2026

▲▲ Improving positively

Trailing net profit reached 16.0bn, rose 8.4bn compared with the same period last year. Key positives came from higher gross profit and lower administrative expenses. Offsetting pressure came mainly from higher selling expenses, higher tax, and higher finance costs. Detailed impact is shown below:

See what is changing ↓
P/E
4.53x
P/B
0.69x
EPS
3,199
BVPS
21,017
ROE
16.5%
ROA
13.9%
Market price
14,500
12 Oct 2026

What Is Changing

On a TTM 2026Q1 basis, MKV is improving on both revenue and margins, suggesting current growth is backed by both scale and operating efficiency — profit is at an all-time high. The next test will be whether this pace holds as the comparison base gets tougher.

Profit bridge

Vs last year · TTM

  1. Gross profit
  2. Administrative expenses
  3. Selling expenses
  4. Tax
  5. Finance costs
Unit: VND bn. Green bars support profit; red bars reduce profit.

A single data point, or a trajectory?

Latest eight quarters · Quý 1/2026

MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24
Revenue36.039.542.233.833.427.730.827.4
LNST1.07.05.72.32.00.31.83.5
Net margin2.91%17.70%13.50%6.71%5.86%0.92%6.00%12.80%

Revenue

36bn

Net income

1bn

Net margin

2.91%

A closer look at what is happening inside the business

A company's statements are read with the questions that fit its type of business.

01

Is the profit sustainable?

Margins are improving and earnings quality is solid — a durable foundation for ROE.

What is driving the margin?

▲▲

Net margin expanded to 10.56%, rising 4.2pp. The main driver is SG&A / Revenue fell 4.3pp and Gross margin rose 0.4pp, moving in line with the stronger net margin (with additional support from Net financial result / Revenue rose 0.3pp).

The improvement comes from core operations — this is a high-quality margin expansion.

Net Margin
10.56%
+4.2pp
Gross Margin
34.90%
+0.4pp
SG&A / Revenue
19.78%
−4.3pp

TTM YoY · 2025Q1 -> 2026Q1

02

Is capital being used efficiently?

Capital efficiency should be read in industry context — ROIC may fluctuate with business specifics.

Is capital being deployed efficiently?

●

Track how much operating profit the business generates on invested capital.

Industry characteristics make ROIC cyclical — this is a reference signal and should be read with the business context.

Balance Sheet

●

ROIC above should be read with industry context — the balance sheet below adds perspective. Balance sheet is exceptionally sound — liabilities at 0.12x equity, with a net cash position equivalent to 0.01x equity.

Inventory ended the period at 18.2bn, roughly 15.7% of total assets.

Over the last 12 months, working capital released 7.2bn of cash, mainly thanks to lower receivables. Pressure from higher inventories and lower payables only partly offset that benefit.

Working Capital Efficiency

▲▲

Working capital is being managed more efficiently, supporting overall capital efficiency. Cash conversion cycle improved by 32.9 days versus the same period last year. The main moves came from DIO rose 1.7 days, DSO fell 46.7 days, and DPO fell 12.1 days.

Improvement comes mainly from faster receivables collection — reflects the quality of receivables management.

Cash conversion cycle remains stretched

CCC stands at 127.2 days, suggesting that working capital remains tied up for a relatively long operating cycle.

Inventory turnover is slowing

DIO increased by +1.7 days, suggesting more capital is being tied up in inventories.

DuPont

What drives ROE?

Net margin 10.6% +4.2pp
Asset turnover 1.31x +0.20x
Financial leverage 1.19x -0.06x
ROE 16.5% +7.6pp

ROE rose from 8.9% to 16.5% — mainly driven by net margin, despite leverage moving in the opposite direction.

03

Is financial risk significant?

Financial risk is low — the company has net cash and CFO reached 21.3bn.

Leverage & Liquidity

▲

Leverage looks fairly comfortable, with net debt / equity at −0.01x and interest coverage at 4.82x.

Debt maturity and the cash buffer remain the two key areas to monitor.

Some leverage signals are missing, so the current read should be treated as contextual.

Net Debt / Equity
−0.01x
Interest Coverage
4.82x
+1.87x
Cash / Debt
None
Short-term Debt / Total Debt
None

TTM YoY · 2025Q1 -> 2026Q1

Cash Flow

●

With safe leverage noted above, cash flow below shows the self-funding capacity. Operating cash flow reached 21.3bn in 2025, against investing cash flow of -22.0bn.

Post-investment cash flow was negative +0.8bn. Financing cash flow was positive 0.0bn.

CFO / net income was 1,63 lần.

Track how much investment can be funded internally from operating cash flow.

Cash capex or FCF data is incomplete, so the cash-conversion view is only partial.

Research synthesis

What this reporting period is showing

The business is showing brighter earnings with improving operating quality. Margin improving shows the business is generating more efficient growth than before. Even so, capital efficiency remains the area to verify in upcoming periods. The residual risk still sits in working capital is tied up too long in the operating cycle, with CCC extended to 127 days.

  • Improvement: operating efficiency is getting better, with trailing-12M net margin at 10.56% after expanding 4.2pp versus the same period last year.
  • Watchpoint: Capital efficiency needs cycle context.
  • Key risk: working capital remains tied up for too long, with cash cycle at 127.2 days.

Questions for the next period

  1. Durability of revenue growth after the current +27,0% YoY pace.

  2. Ability to hold margins around the current 10.56% level.

  3. Cash-flow quality, with operating cash flow currently at 21.3bn in 2025.

From one stock to the whole portfolio

Where does this stock stand
among the rest of your investments?

Each stock is only one part of the wider picture. Looking at investments side by side makes their contribution, risks and opportunities across the portfolio clearer.

How much does this stock
contribute to the portfolio?

Its weight and influence across the assets held for investment.

Is the portfolio
well balanced?

How holdings, sectors and asset groups are distributed in relation to overall risk.

What other opportunities
or risks may be present?

What becomes visible only when investments are viewed together rather than one ticker at a time.

View my portfolio